AbbVie
ABBV
ABBV
1,632 hedge funds and large institutions have $69.9B invested in AbbVie in 2016 Q2 according to their latest regulatory filings, with 97 funds opening new positions, 621 increasing their positions, 697 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
2.71% less ownership
Funds ownership: 69.92% → 67.21% (-2.7%)
11% less repeat investments, than reductions
Existing positions increased: 621 | Existing positions reduced: 697
26% less call options, than puts
Call options by funds: $1.17B | Put options by funds: $1.58B
Holders
1,632
Holding in Top 10
94
Calls
$1.17B
Puts
$1.58B
Top Buyers
| 1 | +$4.67B | |
| 2 | +$217M | |
| 3 | +$116M | |
| 4 |
SUT
SC US (TTGP)
Menlo Park,
California
|
+$87.5M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$83.2M |
Top Sellers
| 1 | -$1.36B | |
| 2 | -$699M | |
| 3 | -$233M | |
| 4 |
AIM
abrdn Investment Management
Edinburgh,
United Kingdom
|
-$210M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$196M |